Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.965714/full |
| _version_ | 1828324697838714880 |
|---|---|
| author | Tao Hu |
| author_facet | Tao Hu |
| author_sort | Tao Hu |
| collection | DOAJ |
| first_indexed | 2024-04-13T19:10:35Z |
| format | Article |
| id | doaj.art-b9c87fabc2a24a39afa5a05e8357338d |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-04-13T19:10:35Z |
| publishDate | 2022-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-b9c87fabc2a24a39afa5a05e8357338d2022-12-22T02:33:52ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-08-011310.3389/fphar.2022.965714965714Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and ManagementTao Huhttps://www.frontiersin.org/articles/10.3389/fphar.2022.965714/fullcytokine release syndromeSARS-CoV-2COVID-1917α-hydroxyprogesterone caproateselective serotonin reuptake inhibitor |
| spellingShingle | Tao Hu Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management Frontiers in Pharmacology cytokine release syndrome SARS-CoV-2 COVID-19 17α-hydroxyprogesterone caproate selective serotonin reuptake inhibitor |
| title | Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management |
| title_full | Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management |
| title_fullStr | Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management |
| title_full_unstemmed | Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management |
| title_short | Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management |
| title_sort | editorial cytokine release syndrome in covid 19 mechanisms and management |
| topic | cytokine release syndrome SARS-CoV-2 COVID-19 17α-hydroxyprogesterone caproate selective serotonin reuptake inhibitor |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2022.965714/full |
| work_keys_str_mv | AT taohu editorialcytokinereleasesyndromeincovid19mechanismsandmanagement |